Medicare director Chris Klomp said the Trump administration is “massively” in support of MA as health insurers cry foul over ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

The federal government has begun using artificial intelligence to review whether certain treatments are necessary for ...

CMS's proposed 0.09% Medicare Advantage rate hike for 2027 triggered a sharp sell-off across US health insurers, signaling ...

Earlier this week, the Centers for Medicare & Medicaid Services (CMS) released the Contract Year (CY) 2027 Medicare Advantage (MA) and Part D ...

CMS selects 15 high-cost prescription drugs for Medicare drug price negotiation program, expanding to include Part B drugs.

The government has proposed new rules for the nation's transplant system that aim to increase use of certain donated organs ...

The CMS has proposed several key changes for 2027, to make sure Medicare "works better for the people it serves." ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Retirees on Medicare will soon be unable to access this incredibly popular service.

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.